मैट्रिक्स
 
 
अंकुर ड्रग्स एंड फार्मा > कंपनी इतिहास > Pharmaceuticals > कंपनी इतिहास का अंकुर ड्रग्स एंड फार्मा - बीएसई: 531683, NSE: ANKURDRUGS

अंकुर ड्रग्स एंड फार्मा

बीएसई: 531683  |  NSE: ANKURDRUGS  |  ISIN: INE238D01012  |  Pharmaceuticals

कंपनी इतिहास - अंकुर ड्रग्स एंड फार्मा
YEAR                       EVENTS
 1995 - Mridol Pharmaceuticals Limited was incorporated on 9th
 February,
        with the Registrar of Companies, Maharashtra at Mumbai and
        certificate of commencement of business was obtained on 7th
        March.  The Company was promoted by Shri Sandeep Parwal and
 Shri
        Harinarayan Attal.
 
      - The Company proposes to set up a project for manufacturing,
        filling and packing of hard gelatine capsules at the Union
        Territory of Daman & Diu.
 
 1996 - The Company's Public Issue of 57,00,000 Equity shares of
 Rs.10/-
        each for cash at par opened for subscription on 15th
 February,
        and was over subscribed.
 
 1997 - The Industrial Development Bank of India has sanctioned a
 Term
        Loan of Rs.490/- Lakhs during the year against the expansion
 of
        the project for the pharmaceutical formulation in addition to
        manufacturing of Empty Hard Gelatine Capsules Filling and
 Blister
        Packing of Capsules.
 
 1998 - The name of the company be and is hereby changed from MRIDOL
        PHARMACEUTICALS LIMITED to ANKUR DRUGS AND PHARMA LIMITED.
 
 1999 - The company is at present manufacturing formulations on loan
        licence basis for reputed companies like Cipla Ltd., Nicholas
        Piramal (India) Ltd.
 
      - The company is consuming energy by way of Electricity and
        LDO/Furnace oil which taken together are important inputs and
        receives the focussed attention of the Board.
 
 
 2003
 
 - Appointed Mr Purnandu Jain as Chairman and Managing Director of the
 company.
 
 
 2007
 
 - The Company has signed a Term Sheet jointly with Labtech of GMBH-
 Germany & APR (Applied Pharma Research) for a exclusive Intellectual
 property rights for a novel technology.
स्रोत: रेलीगरे टेचनोवा

न्यूज़ फ़्लैश

  • MARKET CUES : FIIs ने कैश में `1352 Cr की खरीदारी की
  • MARKET CUES : DIIs ने कैश में `985 Cr की बिकवाली की
  • MARKET CUES : FIIs ने F&O में `2645 Cr की खरीदारी की
  • MARKET CUES : इंडेक्स फ्यूचर्स में `417 Cr की बिकवाली
  • MARKET CUES : इंडेक्स ऑप्शंस में `2929 Cr की खरीदारी
  • MARKET CUES : स्टॉक फ्यूचर्स में `66 Cr की बिकवाली
  • MARKET CUES : स्टॉक ऑप्शन में `199.26 Cr की खरीदारी
  • MACQUARIE ON CHOLA FIN : Outperform रेटिंग, लक्ष्य `300/Sh
  • MACQUARIE ON SBI LIFE : Underperform रेटिंग, लक्ष्य `645/Sh
  • CLSA ON DB CORP : BUY रेटिंग, लक्ष्य `185/Sh

अभी देखें

आवाज़ अड्डा

OUR WINNING PICKS

DID YOU INVEST?

INTRADAY PICKS!

(August 06, 2018)

AT (Rs)



GAIN (Rs)

ALL TIME WINNERS

RECO PRICE

PEAK PRICE

OUR PACKAGES

Super Combo

Powerful mix of both trader and investor packs with timely expert advice.

Technical

Designed especially for traders looking to tap the profit opportunities of volatile markets.

Fundamental

For all investors looking to unearth stocks that are poised to move.